{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:07:03Z","timestamp":1791821223824,"version":"4.3.4"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ejso.2024.109546","type":"journal-article","created":{"date-parts":[[2024,12,15]],"date-time":"2024-12-15T03:38:33Z","timestamp":1734233913000},"page":"109546","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Patterns of recurrence after esophagectomy following neoadjuvant immunochemotherapy in patients with thoracic esophageal squamous cell carcinoma"],"prefix":"10.1016","volume":"51","author":[{"given":"Qiuying","family":"An","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sihan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanjun","family":"Zhen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueying","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanyu","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhao","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiguo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2024.109546_bib1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA A Cancer J Clin"},{"key":"10.1016\/j.ejso.2024.109546_bib2","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1093\/annonc\/mdr433","article-title":"Esophageal carcinoma advances in treatment results for locally advanced disease: review","volume":"23","author":"Herskovic","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2024.109546_bib3","doi-asserted-by":"crossref","first-page":"393","DOI":"10.6004\/jnccn.2023.0019","article-title":"Esophageal and esophagogastric junction cancers, version 2.2023, NCCN clinical practice guidelines in Oncology","volume":"21","author":"Ajani","year":"2023","journal-title":"J Natl Compr Cancer Netw"},{"key":"10.1016\/j.ejso.2024.109546_bib4","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S1470-2045(15)00040-6","article-title":"Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial","volume":"16","author":"Shapiro","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2024.109546_bib5","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.annonc.2022.10.508","article-title":"Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy followed by minimally invasive esophagectomy for locally advanced esophageal squamous cell carcinoma: a prospective multicenter randomized clinical trial","volume":"34","author":"Tang","year":"2023","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2024.109546_bib6","article-title":"Perioperative outcomes of neoadjuvant chemotherapy plus camrelizumab compared with chemotherapy alone and chemoradiotherapy for locally advanced esophageal squamous cell cancer","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.ejso.2024.109546_bib7","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1200\/JCO.20.03614","article-title":"Ten-year outcome of neoadjuvant chemoradiotherapy plus surgery for esophageal cancer: the randomized controlled CROSS trial","volume":"39","author":"Eyck","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejso.2024.109546_bib8","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s13045-021-01164-5","article-title":"Combination strategies to maximize the benefits of cancer immunotherapy","volume":"14","author":"Zhu","year":"2021","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.ejso.2024.109546_bib9","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.39778","article-title":"Evaluation of clinical and safety outcomes of neoadjuvant immunotherapy combined with chemotherapy for patients with resectable esophageal cancer: a systematic review and meta-analysis","volume":"5","author":"Ge","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ejso.2024.109546_bib10","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003497","article-title":"Neoadjuvant programmed cell death 1 blockade combined with chemotherapy for resectable esophageal squamous cell carcinoma","volume":"10","author":"Yang","year":"2022","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.ejso.2024.109546_bib11","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1111\/1759-7714.15291","article-title":"Neoadjuvant chemoimmunotherapy for locally advanced esophageal squamous cell carcinoma: data from literature review and a real-world analysis","volume":"15","author":"Zhang","year":"2024","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.ejso.2024.109546_bib12","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1186\/s12885-021-08747-y","article-title":"Evaluating the effect of Neoadjuvant chemotherapy for esophageal Cancer using the RECIST system with shorter-axis measurements: a retrospective multicenter study","volume":"21","author":"Taniyama","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejso.2024.109546_bib13","article-title":"Evaluation of neoadjuvant immunotherapy and traditional neoadjuvant therapy for resectable esophageal cancer: a systematic review and single-arm and network meta-analysis","volume":"14","author":"Wang","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.ejso.2024.109546_bib14","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1245\/s10434-023-14534-9","article-title":"A comparison of clinicopathologic outcomes and patterns of lymphatic spread across neoadjuvant chemotherapy, neoadjuvant chemoradiotherapy, and neoadjuvant immunochemotherapy in locally advanced esophageal squamous cell carcinoma","volume":"31","author":"Tian","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2024.109546_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijsu.2022.106680","article-title":"Tislelizumab combined with chemotherapy as neoadjuvant therapy for surgically resectable esophageal cancer: a prospective, single-arm, phase II study (TD-NICE)","volume":"103","author":"Yan","year":"2022","journal-title":"Int J Surg"},{"key":"10.1016\/j.ejso.2024.109546_bib16","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s00595-021-02397-0","article-title":"Clinical features and risk factors for early recurrence after esophagectomy following neoadjuvant chemotherapy for esophageal cancer","volume":"52","author":"Kurogochi","year":"2022","journal-title":"Surg Today"},{"key":"10.1016\/j.ejso.2024.109546_bib17","doi-asserted-by":"crossref","DOI":"10.1177\/17588359221075495","article-title":"A population-based study in resected esophageal or gastroesophageal junction cancer aligned with CheckMate 577","volume":"14","author":"Pape","year":"2022","journal-title":"Ther Adv Med Oncol"},{"issue":"24","key":"10.1016\/j.ejso.2024.109546_bib18","first-page":"S0022","article-title":"Neoadjuvant chemotherapy combined with immunotherapy versus neoadjuvant chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinoma","volume":"19","author":"Yu","year":"2024","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ejso.2024.109546_bib19","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1001\/jamasurg.2021.2373","article-title":"Long-term efficacy of neoadjuvant chemoradiotherapy plus surgery for the treatment of locally advanced esophageal squamous cell carcinoma: the NEOCRTEC5010 randomized clinical trial","volume":"156","author":"Yang","year":"2021","journal-title":"JAMA Surg"},{"key":"10.1016\/j.ejso.2024.109546_bib20","doi-asserted-by":"crossref","first-page":"6295","DOI":"10.2147\/CMAR.S182436","article-title":"Anatomy of lymphatic drainage of the esophagus and lymph node metastasis of thoracic esophageal cancer","volume":"10","author":"Wang","year":"2018","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.ejso.2024.109546_bib21","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.jtcvs.2011.09.027","article-title":"Esophageal submucosa: the watershed for esophageal cancer","volume":"142","author":"Raja","year":"2011","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ejso.2024.109546_bib22","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s12885-024-11886-7","article-title":"Increased resected lymph node stations improved survival of esophageal squamous cell carcinoma","volume":"24","author":"Lu","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejso.2024.109546_bib23","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1097\/SLA.0000000000001737","article-title":"Impact of extent of lymphadenectomy on survival, post neoadjuvant chemotherapy and transthoracic esophagectomy","volume":"265","author":"Phillips","year":"2017","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2024.109546_bib24","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/SLA.0000000000004798","article-title":"Impact of lymph node dissection on survival after neoadjuvant chemoradiotherapy for locally advanced esophageal squamous cell carcinoma: from the results of NEOCRTEC5010, a randomized multicenter study","volume":"277","author":"Guo","year":"2023","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2024.109546_bib25","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1002\/ijc.34417","article-title":"Incidence and management of esophageal cancer recurrence to regional lymph nodes after curative esophagectomy","volume":"152","author":"Boerner","year":"2023","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejso.2024.109546_bib26","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/s41392-023-01576-4","article-title":"Lymph node metastasis in cancer progression: molecular mechanisms, clinical significance and therapeutic interventions","volume":"8","author":"Ji","year":"2023","journal-title":"Signal Transduct Targeted Ther"},{"key":"10.1016\/j.ejso.2024.109546_bib27","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jdermsci.2017.12.016","article-title":"Surgical damage to the lymphatic system promotes tumor growth via impaired adaptive immune response","volume":"90","author":"Nakamura","year":"2018","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.ejso.2024.109546_bib28","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.cell.2023.02.021","article-title":"Dynamic CD8(+) T cell responses to cancer immunotherapy in human regional lymph nodes are disrupted in metastatic lymph nodes","volume":"186","author":"Rahim","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.ejso.2024.109546_bib29","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.124507","article-title":"Tumor-draining lymph nodes are pivotal in PD-1\/PD-L1 checkpoint therapy","volume":"3","author":"Fransen","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.ejso.2024.109546_bib30","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/SLA.0000000000005028","article-title":"Extent of lymphadenectomy and long-term survival in esophageal cancer","volume":"277","author":"Gottlieb-Vedi","year":"2023","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2024.109546_bib31","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1016\/j.cell.2022.04.019","article-title":"Lymph node colonization induces tumor-immune tolerance to promote distant metastasis","volume":"185","author":"Reticker-Flynn","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.ejso.2024.109546_bib32","doi-asserted-by":"crossref","first-page":"4197","DOI":"10.7150\/jca.96574","article-title":"Impact of the number of lymph node dissections and a novel risk stratification on the prognosis in elderly locally advanced esophageal adenocarcinoma","volume":"15","author":"Wu","year":"2024","journal-title":"J Cancer"},{"key":"10.1016\/j.ejso.2024.109546_bib33","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.tcb.2023.04.001","article-title":"Lymph nodes: at the intersection of cancer treatment and progression","volume":"33","author":"Reticker-Flynn","year":"2023","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.ejso.2024.109546_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1009315","article-title":"Comparison of McKeown Minimally Invasive Esophagectomy vs sweet esophagectomy for esophageal squamous cell carcinoma: a retrospective study","volume":"12","author":"Yu","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.ejso.2024.109546_bib35","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1097\/SLA.0000000000002280","article-title":"Extended right thoracic approach compared with limited left thoracic approach for patients with middle and lower esophageal squamous cell carcinoma: three-year survival of a prospective, randomized, open-label trial","volume":"267","author":"Li","year":"2018","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2024.109546_bib36","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00000658-200301000-00006","article-title":"Immune responses and prediction of major infection in patients undergoing transhiatal or transthoracic esophagectomy for cancer","volume":"237","author":"van Sandick","year":"2003","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2024.109546_bib37","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10388-021-00886-2","article-title":"Esophageal wall thickness on CT scans: can it predict the T stage of primary thoracic esophageal squamous cell carcinoma?","volume":"19","author":"Wang","year":"2022","journal-title":"Esophagus"},{"key":"10.1016\/j.ejso.2024.109546_bib38","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s00423-022-02430-x","article-title":"Impact of CT-assessed changes in tumor size after neoadjuvant chemotherapy on pathological response and survival of patients with esophageal squamous cell carcinoma","volume":"407","author":"Matsumoto","year":"2022","journal-title":"Langenbeck's Arch Surg"}],"updated-by":[{"DOI":"10.1016\/j.ejso.2024.109572","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000}}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798324016147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798324016147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T04:46:08Z","timestamp":1741927568000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798324016147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0748798324016147"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2024.109546","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.ejso.2024.109572","asserted-by":"object"}]},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patterns of recurrence after esophagectomy following neoadjuvant immunochemotherapy in patients with thoracic esophageal squamous cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2024.109546","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109546"}}